Minnie Kuo

Minnie Kuo currently serves as Chief Development Officer at Pliant Therapeutics, a position held since September 2023. Prior to this, Minnie worked at Vir Biotechnology, Inc. from August 2017 to September 2023, progressing through roles including Senior Vice President and Vice President of Translational and Clinical Development Operations. Experience also includes serving as Director of Clinical Operations at Nektar Therapeutics and Associate Director of Clinical Operations at Gilead Sciences. Other notable positions span across organizations such as ICON plc, Roche, Genentech, PharmaNet/i3 Strategic Resourcing, and UCSD/Pacific Sleep Medicines/Scripps Institute. Minnie holds a Bachelor's degree from UC San Diego and a Master of Science degree from the University of San Francisco, where a Graduate Merit Scholarship was awarded.